Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
Grace En Hui Lim, Ansel Shao Pin Tang, Cheng Han Ng, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 21, Iss. 3, pp. 619-629.e7
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

The global burden of metabolic disease: Data from 2000 to 2019
Nicholas Chew, Cheng Han Ng, Darren Jun Hao Tan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 414-428.e3
Closed Access | Times Cited: 377
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
Jingxuan Quek, Kai En Chan, Zhen Yu Wong, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 20-30
Closed Access | Times Cited: 331
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming‐Hua Zheng, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S17-S31
Open Access | Times Cited: 223
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. 2691-2700
Open Access | Times Cited: 184
Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Cheng Han Ng, Wen Hui Lim, Grace En Hui Lim, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 4, pp. 931-939.e5
Open Access | Times Cited: 108
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 483-496
Open Access | Times Cited: 76
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 76
Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?
Mariana M. Ramírez-Mejía, Carlos Jiménez-Gutiérrez, Mohammed Eslam, et al.
Hepatology International (2023) Vol. 18, Iss. 1, pp. 168-178
Closed Access | Times Cited: 51
Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid
Jijun Tan, Ruizhi Hu, Jiatai Gong, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 43
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 2
miR‐18a‐5p/PXR/SREBP2 Was Involved in MAFLD Associated With Methyl Tert‐Butyl Ether Among Petrol Station Workers
H. Wang, Mingxiao Guo, Fengtao Cui, et al.
Liver International (2025) Vol. 45, Iss. 2
Closed Access | Times Cited: 1
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
Cheng Han Ng, Kai En Chan, Yip Han Chin, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 565-574
Open Access | Times Cited: 64
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 790-801
Open Access | Times Cited: 55
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
Jingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Endocrine Practice (2022) Vol. 28, Iss. 7, pp. 667-672
Closed Access | Times Cited: 52
MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
Hyoeun Kim, Chan Joo Lee, Sang Hoon Ahn, et al.
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 10, pp. 4919-4928
Closed Access | Times Cited: 47
Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018
Zhilan Xie, Ruxianguli Aimuzi, Mingyu Si, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 27
The Global Epidemic of Metabolic Fatty Liver Disease
Ethan C. Z. Lee, Vickram Vijay Anand, Alex C. Razavi, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 199-210
Closed Access | Times Cited: 12
Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China
Jingfeng Chen, Zhuo-Qing Wu, H. Liu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1346-1357
Open Access | Times Cited: 12
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease
Niki Katsiki, Genovefa Kolovou, Michal Vrablı́k
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
Di Shen, Xintian Cai, Junli Hu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1623-1638
Open Access | Times Cited: 1
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, et al.
Annals of Hepatology (2022) Vol. 28, Iss. 1, pp. 100762-100762
Open Access | Times Cited: 36
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
Jieling Xiao, Cheng Han Ng, Kai En Chan, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 4, pp. 656-665
Open Access | Times Cited: 31
Copper homeostasis dysregulation promoting cell damage and the association with liver diseases
Tao Liu, Yali Liu, Feiyu Zhang, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 17
ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
Paolo Convertini, Anna Santarsiero, Simona Todisco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top